[go: up one dir, main page]

WO2008036157A3 - Prophylactic and therapeutic treatment of avian influenza infections in animals - Google Patents

Prophylactic and therapeutic treatment of avian influenza infections in animals Download PDF

Info

Publication number
WO2008036157A3
WO2008036157A3 PCT/US2007/017953 US2007017953W WO2008036157A3 WO 2008036157 A3 WO2008036157 A3 WO 2008036157A3 US 2007017953 W US2007017953 W US 2007017953W WO 2008036157 A3 WO2008036157 A3 WO 2008036157A3
Authority
WO
WIPO (PCT)
Prior art keywords
avian influenza
animals
prophylactic
therapeutic treatment
influenza infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/017953
Other languages
French (fr)
Other versions
WO2008036157A2 (en
Inventor
Hal Siegel
Michael K Wilhelm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immuneregen Biosciences Inc
Original Assignee
Immuneregen Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuneregen Biosciences Inc filed Critical Immuneregen Biosciences Inc
Priority to CA002660856A priority Critical patent/CA2660856A1/en
Publication of WO2008036157A2 publication Critical patent/WO2008036157A2/en
Publication of WO2008036157A3 publication Critical patent/WO2008036157A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/046—Tachykinins, e.g. eledoisins, substance P; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Substance P analogs are useful for treating and protecting animals against avian influenza. The Substance P analogs can be administered via inhalation therapy, intravenously, intramuscularly, sublingually or by other methods. Avian influenza can be prevented in animals and disease indicia are reduced by treatment with Substance P analogs.
PCT/US2007/017953 2006-08-15 2007-08-14 Prophylactic and therapeutic treatment of avian influenza infections in animals Ceased WO2008036157A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002660856A CA2660856A1 (en) 2006-08-15 2007-08-14 Prophylactic and therapeutic treatment of avian influenza infections in animals

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US83763506P 2006-08-15 2006-08-15
US60/837,635 2006-08-15
US82872806P 2006-10-09 2006-10-09
US60/828,728 2006-10-09
US86690106P 2006-11-22 2006-11-22
US60/866,901 2006-11-22
US89900407P 2007-02-02 2007-02-02
US60/899,004 2007-02-02
US91537307P 2007-05-01 2007-05-01
US60/915,373 2007-05-01

Publications (2)

Publication Number Publication Date
WO2008036157A2 WO2008036157A2 (en) 2008-03-27
WO2008036157A3 true WO2008036157A3 (en) 2008-12-24

Family

ID=39201031

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/017953 Ceased WO2008036157A2 (en) 2006-08-15 2007-08-14 Prophylactic and therapeutic treatment of avian influenza infections in animals

Country Status (2)

Country Link
CA (1) CA2660856A1 (en)
WO (1) WO2008036157A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170065663A1 (en) * 2014-05-02 2017-03-09 New Amsterdam Sciences Substance and method for treating influenza

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003194A2 (en) * 1996-07-23 1998-01-29 Witten Mark L Substance p treatment for immunostimulation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003194A2 (en) * 1996-07-23 1998-01-29 Witten Mark L Substance p treatment for immunostimulation

Also Published As

Publication number Publication date
CA2660856A1 (en) 2008-03-27
WO2008036157A2 (en) 2008-03-27

Similar Documents

Publication Publication Date Title
HK1198869A1 (en) Combination treatments for hepatitis c
WO2009065406A3 (en) Novel cyclic hydrocarbon compounds for the treatment of diseases
WO2008063727A3 (en) Combination therapy for treatment of viral infections
BRPI0916235A2 (en) compound, pharmaceutical composition, use of the compound or composition, and method for treating an hcv infected patient
EA201270221A1 (en) TREATMENT OF CROWN DISEASE WITH LACQUINIMODE
MX374396B (en) SUBLINGUAL FENTANYL SPRAY.
MX341883B (en) Pharmaceutical composition for treatment and prevention of cancer.
BRPI0806392A8 (en) use of aclidinium, aclidinium, treatment or prevention method and pharmaceutical composition
WO2009129470A3 (en) Methods for treating herpes virus infections
MX2010002498A (en) Methods of treating or preventing respiratory tract infection comprising administering cholecalciferol.
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
WO2007098106A3 (en) Respiratory tract delivery of interferon-tau
WO2008024843A3 (en) Combination therapy method for treating hepatitis c virus infection and pharmaceutical compositions for use therein
MX2010002735A (en) Titration package for neramexane and its use in the treatment of an inner ear disorder.
EA201171273A1 (en) MEANS FOR PREVENTION AND TREATMENT OF HIGHLY PATHOGENIC INFECTIOUS DISEASES
WO2010045417A3 (en) Combination therapies for the treatment of obesity
WO2009109654A8 (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1
PH12013500559A1 (en) Combination therapy for treating hcv infection
WO2008045378A3 (en) Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin
WO2008070010A3 (en) Hydroxylamine derivatives for the treatment of stroke
BRPI1008103A2 (en) "isolated short chain peptide, pharmaceutical composition, compounds, method of preventing or treating diseases, medicament for treating / reducing medical conditions and use of the compounds"
WO2005094554A3 (en) Therapeutic agents, methods, and treatments
WO2010045522A3 (en) Combination therapies for the treatment of obesity
WO2010138419A3 (en) Materials and methods for treating viral infections
WO2009006246A8 (en) Use of tight junction antagonists in the treatment of acute long injury and acute respiratory distress syndrome

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07836793

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2660856

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC, EPO FORM 1205A OF 15.05.2009

122 Ep: pct application non-entry in european phase

Ref document number: 07836793

Country of ref document: EP

Kind code of ref document: A2